Lucid Diagnostics (LUCD) Assets (2020 - 2026)

Lucid Diagnostics' Assets history runs 7 years deep, the most recent figure standing at $34.1 million for Q1 2026.

• Quarterly Assets rose 3.92% year-over-year to $34.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $34.1 million (up 3.92% YoY) and the FY2025 annual result came in at $40.4 million, up 31.68% from the prior year.
• Assets was $34.1 million for Q1 2026 at Lucid Diagnostics, down from $40.4 million in the prior quarter.
• Across five years, Assets topped out at $62.1 million in Q1 2022 and bottomed at $22.6 million in Q3 2024.
• A 5-year average of $38.2 million and a median of $34.1 million in 2024 frame the typical range for Assets.
• Peak annual rise in Assets reached 1064.21% in 2022, while the deepest fall reached 44.9% in 2022.
• Lucid Diagnostics' Assets stood at $32.5 million in 2022, then retreated by 16.12% to $27.3 million in 2023, then grew by 12.63% to $30.7 million in 2024, then jumped by 31.68% to $40.4 million in 2025, then fell by 15.74% to $34.1 million in 2026.
• Business Quant data shows LUCD's Assets at $34.1 million in Q1 2026, $40.4 million in Q4 2025, and $53.2 million in Q3 2025.